Direct oral anticoagulants and venous thromboembolism

被引:21
作者
Franchini, Massimo [1 ]
Mannucci, Pier Mannuccio [2 ,3 ]
机构
[1] Carlo Poma Hosp, Dept Transfus Med & Hematol, Mantua, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] Univ Milan, Milan, Italy
关键词
FACTOR XA INHIBITOR; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; VITAMIN-K ANTAGONISTS; DEEP-VEIN THROMBOSIS; DABIGATRAN ETEXILATE; DOUBLE-BLIND; CLINICAL-PRACTICE; STANDARD THERAPY; ENOXAPARIN;
D O I
10.1183/16000617.0025-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary embolism, is a major clinical concern associated with significant morbidity and mortality. The cornerstone of management of VTE is anticoagulation, and traditional anticoagulants include parenteral heparins and oral vitamin K antagonists. Recently, new oral anticoagulant drugs have been developed and licensed, including direct factor Xa inhibitors (e.g. rivaroxaban, apixaban and edoxaban) and thrombin inhibitors (e.g. dabigatran etexilate). This narrative review focusses on the characteristics of these direct anticoagulants and the main results of published clinical studies on their use in the prevention and treatment of VTE.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 60 条
[1]   Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study [J].
Ageno, Walter ;
Mantovani, Lorenzo G. ;
Haas, Sylvia ;
Kreutz, Reinhold ;
Monje, Danja ;
Schneider, Jonas ;
Van Eickels, Martin ;
Gebel, Martin ;
Zell, Elizabeth ;
Turpie, Alexander G. G. .
LANCET HAEMATOLOGY, 2016, 3 (01) :E12-E21
[2]   XALIA: Rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis [J].
Ageno W. ;
Mantovani L.G. ;
Haas S. ;
Kreutz R. ;
Haupt V. ;
Schneider J. ;
Turpie A.G.G. .
Thrombosis Journal, 12 (1)
[3]   Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Ageno, Walter ;
Gallus, Alexander S. ;
Wittkowsky, Ann ;
Crowther, Mark ;
Hylek, Elaine M. ;
Palareti, Gualtiero .
CHEST, 2012, 141 (02) :E44S-E88S
[4]   The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry [J].
Agnelli G. ;
Gitt A.K. ;
Bauersachs R. ;
Fronk E.-M. ;
Laeis P. ;
Mismetti P. ;
Monreal M. ;
Willich S.N. ;
Wolf W.-P. ;
Cohen A.T. ;
Brodmann M. ;
Rief P. ;
Eischer L. ;
Stoshikj S. ;
Hirschl M. ;
Weinmann S. ;
Marschang P. ;
Abbadie F. ;
Achkar A. ;
Addala A. ;
Adnet F. ;
Alexandra J.-F. ;
Aquilanti S. ;
Belhassane A. ;
Benaroya A. ;
Berremili T. ;
Grenot M.C. ;
Birr V. ;
Holtea D. ;
Bonnin C. ;
Bosler F. ;
Durand M.-G.B. ;
Brisot D. ;
Brousse C. ;
De La Fuente T. ;
Cayman R. ;
Cazaubon M. ;
Champion O. ;
Chanut M. ;
Chevalet P. ;
Connault J. ;
Durant C. ;
Constans J. ;
Cordeanu M. ;
Couturaud F. ;
Lacut K. ;
De Dedker L. ;
Decoulx E. ;
Derrien B. ;
Diamand J.-M. .
Thrombosis Journal, 13 (1)
[5]   Oral Apixaban for the Treatment of Acute Venous Thromboembolism [J].
Agnelli, Giancarlo ;
Buller, Harry R. ;
Cohen, Alexander ;
Curto, Madelyn ;
Gallus, Alexander S. ;
Johnson, Margot ;
Masiukiewicz, Urszula ;
Pak, Raphael ;
Thompson, John ;
Raskob, Gary E. ;
Weitz, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :799-808
[6]   Apixaban for Extended Treatment of Venous Thromboembolism [J].
Agnelli, Giancarlo ;
Buller, Harry R. ;
Cohen, Alexander ;
Curto, Madelyn ;
Gallus, Alexander S. ;
Johnson, Margot ;
Porcari, Anthony ;
Raskob, Gary E. ;
Weitz, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08) :699-708
[7]   Current Concepts: Acute Pulmonary Embolism. [J].
Agnelli, Giancarlo ;
Becattini, Cecilia .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :266-274
[8]   Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].
Bauersachs, Rupert ;
Berkowitz, Scott D. ;
Brenner, Benjamin ;
Buller, Harry R. ;
Decousus, Herve ;
Gallus, Alex S. ;
Lensing, Anthonie W. ;
Misselwitz, Frank ;
Prins, Martin H. ;
Raskob, Gary E. ;
Segers, Annelise ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Bounameaux, Henri ;
Cohen, Alexander ;
Davidson, Bruce L. ;
Piovella, Franco ;
Schellong, Sebastian .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510
[9]   Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism [J].
Bueller, Harry R. ;
Decousus, Herve ;
Grosso, Michael A. ;
Mercuri, Michele ;
Middeldorp, Saskia ;
Prins, Martin H. ;
Raskob, Gary E. ;
Schellong, Sebastian M. ;
Schwocho, Lee ;
Segers, Annelise ;
Shi, Minggao ;
Verhamme, Peter ;
Wells, Phil .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (15) :1406-1415
[10]   Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study [J].
Buller, H. ;
Deitchman, D. ;
Prins, M. ;
Segers, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) :1313-1318